Toshikuni Nobuyuki, Matsue Yasuhiro, Ozaki Kazuaki, Yamada Kaho, Hayashi Nobuhiko, Tsuchishima Mutsumi, Tsutsumi Mikihiro
Department of Hepatology, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Radiol Oncol. 2017 Jul 18;51(3):263-269. doi: 10.1515/raon-2017-0028. eCollection 2017 Sep.
During ultrasound-guided radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC), high echoic areas due to RFA-induced microbubbles can help calculate the extent of ablation. However, these areas also decrease visualization of target tumors, making it difficult to assess whether they completely cover the tumors. To estimate the effects of RFA more precisely, we used an image fusion system (IFS).
We enrolled patients with a single HCC who received RFA with or without the IFS. In the IFS group, we drew a spherical marker along the contour of a target tumor on reference images immediately after administering RFA so that the synchronized spherical marker represented the contour of the target tumor on real-time ultrasound images. When the high echoic area completely covered the marker, we considered the ablation to be complete. We compared outcomes between the IFS and control groups.
We enrolled 25 patients and 20 controls, and the baseline characteristics were similar between the two groups. The complete ablation rates during the first RFA session were significantly higher in the IFS group compared with those in the control group (88.0% . 60.0%, = 0.041). The number of RFA sessions was significantly smaller in the IFS group compared with that in the control group (1.1 ± 0.3 . 1.5 ± 0.7, = 0.016).
The study suggested that the IFS enables a more precise estimation of the effects of RFA on HCC, contributing to enhanced treatment efficacy and minimized patient burden.
在超声引导下对肝细胞癌(HCC)进行射频消融(RFA)时,RFA诱导产生的微泡所形成的高回声区域有助于计算消融范围。然而,这些区域也会降低目标肿瘤的可视性,从而难以评估它们是否完全覆盖肿瘤。为了更精确地评估RFA的效果,我们使用了图像融合系统(IFS)。
我们纳入了接受有或没有IFS辅助的RFA治疗的单发HCC患者。在IFS组中,RFA治疗后立即在参考图像上沿着目标肿瘤的轮廓绘制一个球形标记,以便同步的球形标记在实时超声图像上代表目标肿瘤的轮廓。当高回声区域完全覆盖该标记时,我们认为消融完成。我们比较了IFS组和对照组的结果。
我们纳入了25例患者和20例对照,两组的基线特征相似。IFS组首次RFA治疗期间的完全消融率显著高于对照组(88.0%对60.0%,P = 0.041)。IFS组的RFA治疗次数显著少于对照组(1.1±0.3对1.5±0.7,P = 0.016)。
该研究表明,IFS能够更精确地评估RFA对HCC的效果,有助于提高治疗效果并减轻患者负担。